Investing
Pfizer, GameStop and Roku: Investments in the Spotlight
Bloomberg Wealth reviews assets that made a splash this week.
This article is for subscribers only.
Pfizer Inc. said Wednesday that a third shot of its Covid vaccine may be needed to help boost resistance against the omicron variant of the virus. The announcement helped allay fears that the new strain would be entirely resistant to the vaccines currently in use, though it had little effect on shares, which dropped less than a percent.
The company’s stock surged after the pandemic arrived in the U.S. and the hunt to develop a vaccine began. Since its March 2020 low, shares of the drugmaker have roughly doubled.